1)Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome:from bench to bedside. Fam Cancer 7:41-52, 2008
2)Mandal R, Samstein RM, Lee KW, et al. Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response. Science 364:485-491, 2019
3)Luchini C, Bibeau F, Ligtenberg MJL, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden:a systematic review-based approach. Ann Oncol 30:1232-1243, 2019
4)山口達郎,関根茂樹,山田真善.悪性腫瘍に対するマイクロサテライト不安定性検査およびミスマッチ修復タンパク質に対する免疫組織化学検査の利用に関する見解ver.2.2023 https://jsht-info.jp/wp/wp-content/uploads/2023/09/28e3da4a24e0e3a04aab229839adf7c2.pdf(2023年10月30日閲覧)
5)Bando H, Okamoto W, Fukui T, et al. Utility of the quasi-monomorphic variation range in unresectable metastatic colorectal cancer patients. Cancer Sci 109:3411-3415, 2018
6)関根茂樹.ミスマッチ修復異常の検査.病理と臨 40:569-576, 2022
7)Ladabaum U, Ford JM, Martel M, et al. American Gastroenterological Association technical review on the diagnosis and management of Lynch syndrome. Gastroenterology 149:783-813, 2015
8)Loughrey MB, McGrath J, Coleman HG, et al. Identifying mismatch repair-deficient colon cancer:near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series. Histopathology 78:401-413, 2021
9)Akagi K, Oki E, Taniguchi H, et al. Real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci 112:1105-1113, 2021
10)Fujita M, Liu X, Iwasaki Y, et al. Population-based screening for hereditary colorectal cancer variants in Japan. Clin Gastroenterol Hepatol 20:2132-2141, 2022
11)Vasen HFA, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138:2300-2306, 2010
12)大腸癌研究会(編).遺伝性大腸癌診療ガイドライン2020年版.金原出版,2020
13)Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer:a cost-effectiveness analysis. Ann Intern Med 155:69-79, 2011
14)Abu-Ghazaleh N, Kaushik V, Gorelik A, et al. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer:Systematic review and meta-analysis. Genet Med 24:971-985, 2022
15)Li D, Hoodfar E, Jiang SF, et al. Comparison of universal versus age-restricted screening of colorectal tumors for Lynch syndrome using mismatch repair immunohistochemistry:A cohort study. Ann Intern Med 171:19-26, 2019
16)NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial high-risk Assessment:Colorectal. Ver 2. 2023
17)Ito T, Suzuki O, Kamae N, et al. Comprehensive analysis of DNA mismatch repair-deficient gastric cancer in a Japanese hospital-based population. Jpn J Clin Oncol 51:886-894, 2021
18)Ito T, Ishida H, Suzuki O, et al. Prevalence and molecular characterization of defective DNA mismatch repair in small-bowel carcinoma in a Japanese hospital-based population. J Anus Rectum Colon 4:165-173, 2020
19)Yamamoto A, Yamaguchi T, Suzuki O, et al. Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population. Jpn J Clin Oncol 51:60-69, 2021
20)Ito T, Kono K, Eguchi H, et al. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population. Jpn J Clin Oncol 50:80-88, 2020
21)Kagawa M, Kawakami S, Yamamoto A, et al. Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population. Int J Clin Oncol 26:1524-1532, 2021
22)PicóMD, Castillejo A, Murcia Ó, et al. Clinical and pathological characterization of Lynch-like syndrome. Clin Gastroenterol Hepatol 18:368-374, 2020
23)Chika N, Eguchi H, Kumamoto K, et al. Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population. Jpn J Clin Oncol 47:108-117, 2017